JPRN-UMIN000013743已完成未知
Therapeutic effect of Peg-IFN therapy combined with RBV and telaprevir(TVR) on patients with chronic hepatitis C - Therapeutic effect of telaprevir(TVR) on patients with chronic hepatitis C
Division of digestive and lifestyle disease, Kagoshima university graduate school of medical and dental sciences0 个研究点目标入组 300 人开始时间: 2014年4月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who did not fulfill the criteria to receive the approved Peg-IFN-alpha2b/RBV/telaprevir treatment
研究者
相似试验
招募中
不适用
Therapeutic effect of Peg-IFN therapy combined with RBV and simeprevir(SMV) on patients with chronic hepatitis C - a multicenter studyChronic hepatitis CJPRN-UMIN000013749Division of digestive and lifestyle disease, Kagoshima university graduate school of medical and dental sciences300
已完成
不适用
Efficacy and safety of peg-IFN+RBV combined therapy in failure of direct antiviral agents therapy for chronic hepatitis C and liver cirrhosis CChronic hepatitis and compensated liver cirrhosis, type CJPRN-UMIN000017988Faculty of Medicine, Kyushu University Dept. of Medicine and Biosyste
已完成
4 期
Treatment efficacy of short-term PEG-IFN alpha for chronic hepatitis C patients with genotype 2 and low viral roadchronic hepatitis CJPRN-UMIN000001170Gunma Liver Study Group220
招募中
不适用
Effect of combination therapy of Pegylated interferon- Alpha 2a, Sofosbuvir and Ribavirin for 12 weeks versus combination of Sofosbuvir and Ribavirin for 24 weeks on viral loads in HCV Genotype 3 chronic hepatitis & compensated cirrhosis patientsHCV genotype 3 related chronic hepatitis & compensated cirrhosisSLCTR/2017/007Department of Hepatology Bangabandhu Sheikh Mujib Medical University
未知
不适用
Efficacy of long term combination therapy of PEG-IFN-alpha-2b and Ribavirin for patients with chronic hepatitis CJPRN-C000000235Department of Hepatology, Graduate School of Medicine, Osaka City University300